Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How does sharewise work?

1

Sign up for free

Get yourself a free user account

Show more
2

Look for a stock/index

Choose a specific stock or index

Show more
3

Discuss

Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard

Show more
4

Engage

Help us make sharewise better and help us in making it a success

Show more
sharewise ist auf Deutsch und Englisch verfügbar.
sharewise is available in German and English.

Top Buy/Sell (This Month)

Security Price Target price
NVIDIA Corp. €178.04 €216.93
Palo Alto Networks €236.10 €270.96
Zscaler Inc €113.48 €263.81
Security Price Target price
HP Inc. €22.19 €16.33
Sivers Ima Holding Ab ? -
General Mills Inc. €28.75 €40.00

Many tell you which stocks to buy.

We measure how often they are right!

Portfolios of our members

A.D.S.....8
Total
€113,909
Cash
€8,908.5
Performance (%)
13.909%

Pros and Cons of these stocks (New Predictions)

Digital Brands Group Inc.

WKN: A40U2V / Name: Digital Brands Group Inc. / Stock / ? /

Pros
Cons
1
Risky Investment
Abivax S.A.

WKN: A14UQC / Name: Abivax / Stock / Biotechnology & Medical Research / Small Cap /

Pros
1
Revenue growth > 30% per year expected
1
EBIT growth > 30% per year expected
1
Rising EBIT margin expected
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!

Tops & Flops S&P 500

Security Price Change(%) (%)
Coty Inc €1.71 6.250%
Kimberly-Clark Corp €85.95 5.690%
Clorox Co. €81.68 5.570%
Progressive Corp. €177.20 5.470%
Everest Reinsurance €290.20 5.380%
Security Price Change(%) (%)
Micron Technology Inc. €755.00 -12.160%
Ipg Photonics €93.10 -11.640%
Teradyne Inc. €310.70 -11.530%
Intel Corp. €85.89 -10.900%
Qualcomm Inc. €187.04 -10.490%

Courses

Key figures for stocks: https://unsplash.com/@markusspiske?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText
Key figures for stocks
Keeping an eye on the various key figures is important. We tell you what they mean.
sharewise advanced features:
sharewise advanced features
You learn how to find  the latest news and find great financial information about your stocks.
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.

For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#

Predictions

buy
Canadian Pacific City Kansas Ltd.

Start price
Target price
Perf. (%)
€78.06
22:15
-
05.06.27
0.00%
08:04

buy
Union Pacific Corp.

Start price
Target price
Perf. (%)
€236.30
22:15
-
05.06.27
0.00%
22:25

buy
Nike Inc. B

Start price
Target price
Perf. (%)
€37.29
22:00
-
05.06.29
0.00%
22:25

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Well known brand
Market Leader or Top 3
buy
adidas AG

Start price
Target price
Perf. (%)
€161.00
21:59
-
05.06.29
-0.12%
22:25

Could be very worthwhile Investment >20% year
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model

Top News

News

Affirm's Expanded CPP Investments Deal Supports $8B in Loan Volume
Affirm's Expanded CPP Investments Deal Supports $8B in Loan Volume

Affirm Holdings, Inc. AFRM has renewed and expanded its funding partnership with Canada Pension Plan Investment Board (CPP Investments). Under the new 24-month forward-flow agreement, CPP

Cencora's Specialty Supply Chain: Where COR's Growth Is Headed
Cencora's Specialty Supply Chain: Where COR's Growth Is Headed

Cencora COR is trying to do more than move pharmaceuticals from point A to point B. The company is leaning into higher-value services that help manufacturers reach community sites of care, while

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

Glaukos Corporation’s GKOS growth prospects are supported by the continued expansion of interventional glaucoma, growing clinical and commercial synergies between iDose TR and iStent infinite, and

Celanese Streamlines Engineered Materials Network Across Asia
Celanese Streamlines Engineered Materials Network Across Asia

Celanese Corporation CE is shifting production from its Engineered Materials compounding facility in Ulsan, South Korea, to its plants in Nanjing and Shenzhen, China, and Silvassa, India. The move

ICLR Earnings Reset: What the Accounting Probe Changed
ICLR Earnings Reset: What the Accounting Probe Changed

ICON plc ICLR is moving through a credibility and earnings reset that is now as much about controls as it is about demand. The company has laid out the scope of its accounting findings, flagged

AMT Stock Rallies 10.5% Year-to-Date: Will the Momentum Last?
AMT Stock Rallies 10.5% Year-to-Date: Will the Momentum Last?

American Tower AMT shares have risen 10.5% in the year-to-date period compared with the industry’s 9.0% growth.

This Zacks Rank #3 (Hold) company is well-positioned to benefit from long-term growth

Block's Cash App Unveils NFC-Powered Tags for Faster Payments
Block's Cash App Unveils NFC-Powered Tags for Faster Payments

Block’s XYZ Cash App, the popular peer-to-peer payment platform, is introducing a new way to pay with the launch of Cash App Tags. These NFC-enabled physical payment accessories allow customers to

Here's Why Investors Should Hold on to Teladoc Health Stock for Now
Here's Why Investors Should Hold on to Teladoc Health Stock for Now

Teladoc Health, Inc. TDOC is a pioneer and global leader in the telemedicine industry. It has a broad international presence, serving clients, supporting medical operations and reaching members

AGEN Early Access Revenues Signal a New Path Ahead of Approval
AGEN Early Access Revenues Signal a New Path Ahead of Approval

Agenus AGEN is taking an uncommon route to validate demand for its lead immuno-oncology combination, botensilimab plus balstilimab (BOT+BAL), before a traditional launch. Instead of waiting for full

Contest

Compete in Catch the Monkey ...

... and win a prize!

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren

Leeway

Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.

Kostenlos ausprobieren

Heibel Ticker

sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.

Kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren